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Aphosphatase cascade bywhich rewarding
stimuli control nucleosomal response
Alexandre Stipanovich1,2,3*, Emmanuel Valjent1,2,3*, Miriam Matamales1,2,3*, Akinori Nishi4,5, Jung-Hyuck Ahn5,
Matthieu Maroteaux1,2,3, Jesus Bertran-Gonzalez1,2,3, Karen Brami-Cherrier1,2,3, Herve´ Enslen1,2,3,
Anne-Gae¨lle Corbille´1,2,3, Odile Filhol6, Angus C. Nairn5,7, Paul Greengard5, Denis Herve´1,2,3
& Jean-Antoine Girault1,2,3
Dopamine orchestrates motor behaviour and reward-driven learning. Perturbations of dopamine signalling have been
implicated in several neurological and psychiatric disorders, and in drug addiction. The actions of dopamine are mediated in
part by the regulation of gene expression in the striatum, through mechanisms that are not fully understood. Here we show
that drugs of abuse, as well as food reinforcement learning, promote the nuclear accumulation of 32-kDa
dopamine-regulated and cyclic-AMP-regulated phosphoprotein (DARPP-32). This accumulation is mediated through a
signalling cascade involving dopamine D1 receptors, cAMP-dependent activation of protein phosphatase-2A,
dephosphorylation of DARPP-32 at Ser 97 and inhibition of its nuclear export. The nuclear accumulation of DARPP-32, a
potent inhibitor of protein phosphatase-1, increases the phosphorylation of histone H3, an important component of
nucleosomal response. Mutation of Ser 97 profoundly alters behavioural effects of drugs of abuse and decreases motivation
for food, underlining the functional importance of this signalling cascade.
Midbrain dopamine neurons, activated after unexpected rewarding
stimuli, are essential in reinforcement learning1. Drugs of abuse
mimic the physiological action of dopamine neurons by increasing
their firing rate or preventing the uptake of dopamine. Thus, they
enhance extracellular dopamine levels in the forebrain, especially in
the nucleus accumbens (NAc), a key structure required for the rein-
forcing effects of addictive drugs2–4. To understand how dopamine
mediates natural or pathological reinforcement learning, it is neces-
sary to identify the intracellular events that trigger gene transcription
alterations supporting long-lasting synaptic changes5–7. DARPP-32
(ref. 8) is a prominent mediator of dopamine signalling in the stria-
tum9 and is highly enriched in striatal medium-size spiny GABA
neurons10. After activation of the dopamine D1 receptor (D1R),
DARPP-32 is phosphorylated by cAMP-dependent protein kinase
(PKA) at Thr 34 and converted into a potent inhibitor of the multi-
functional serine/threonine protein phosphatase-1 (PP1)11. DARPP-
32-mediated inhibition of PP1 increases the phosphorylation of
neurotransmitter receptors and ion channels crucial for synaptic
function and plasticity9. DARPP-32 also regulates nuclear events,
as demonstrated by alterations of drug-induced gene expression in
mice lacking DARPP-32 or bearing a point mutation of Thr 34
(refs 12, 13). Part of the control exerted by DARPP-32 on transcrip-
tion is mediated by activation of the extracellular signal-regulated
kinase pathway, which is dependent on the concomitant stimulation
of D1R and glutamateN-methyl-D-aspartate receptors13,14. However,
the precise mechanisms of information transfer from the cytoplasm
to the nucleus of striatal neurons are still poorly understood.
Drugs and incentive learning increase nuclear DARPP-32
DARPP-32 has been extensively characterized as a cytoplasmic
protein9. In contrast, electron microscopy has revealed
immunoreactivity to DARPP-32 in the nucleus of some striatal
medium-size spiny neurons15, although the significance of this obser-
vation has not been explained. In mice treated with D-amphetamine,
immunoreactivity to DARPP-32 phosphorylated on Thr 34 was
strong in the nuclei of striatal neurons (Fig. 1a). D-Amphetamine
also increased total DARPP-32 immunoreactivity in nuclei (Fig. 1a,
b). Cocaine induced a rapid accumulation of DARPP-32 in the nuc-
leus that lasted several hours (Fig. 1b and Supplementary Fig. 1a).
D-Amphetamine and cocaine triggered the nuclear accumulation of
DARPP-32 in both the dorsal striatum and the NAc (data not
shown). In contrast, morphine increased nuclear DARPP-32 only
in the NAc shell (Fig. 1b and Supplementary Fig. 1b), where it
potently increases dopamine release16. A reinforcement learning
model, in whichmice nose-poked for food, also triggered the nuclear
accumulation of DARPP-32 in the dorsal striatum and in the NAc
shell and core (Fig. 1c). In mice receiving no food, or in yoked mice
that received food when the ‘active’ animal nose-poked, no nuclear
accumulation was observed (Fig. 1c).
In drd1a-EGFP mice, which specifically express enhanced green
fluorescent protein (EGFP) in striatonigral neurons under the
control of the D1R promoter (drd1a)17, nuclear accumulation of
DARPP-32 occurred in D1R-expressing neurons 8min after cocaine
injection (Supplementary Fig. 2a). Cocaine-induced rapid nuclear
accumulation of DARPP-32 was not observed in D1R-null mice
(Supplementary Fig. 2b), indicating the requirement for D1R. In
striatal neurons in culture, DARPP-32 immunofluorescence was
predominantly cytoplasmic; application of SKF81297, aD1R agonist,
induced its nuclear accumulation, which was prevented by a D1R
antagonist, SCH23390, or a cAMP antagonist, Rp-cAMPS (Supple-
mentary Fig. 3a, b). Conversely, a cAMP analogue, Sp-5,6-DCl-
cBIMPS, increased nuclear DARPP-32 immunoreactivity in a
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time-dependent manner (Supplementary Fig. 3c). Similar results
were obtained with DARPP-32 fused to EGFP (D32–GFP), co-
expressed with D1R in striatal neurons in culture (Supplementary
Fig. 4a–c). Taken together, our results show that nuclear accumula-
tion of DARPP-32 in response to physiological reward-controlled
learning or to drugs of abuse was mediated by D1R and that cAMP
was necessary and sufficient for this effect.
Ser 97 phosphorylation controls DARPP-32 localization
Leptomycin B (LMB), a specific inhibitor of CRM1-mediated nuc-
lear export18, induced a rapid nuclear accumulation of endogenous
DARPP-32 (Fig. 2a) or transfected D32–GFP (Supplementary Fig. 5a
and Supplementary Video) in virtually all neurons. At residues 103–
111 of DARPP-32 we identified a putative nuclear export signal
(NES; Fig. 2b) that was homologous to sequences known to bind
CRM1 (ref. 19). Mutation of Leu 103 or Leu 109 to alanine induced
a marked accumulation of D32–GFP in the nucleus (Fig. 2c), con-
firming the critical role of this sequence in nuclear export. Similar
results were observed in Chinese hamster ovary cells (Supplementary
Fig. 5b, c).We also found that the amino-terminal region of DARPP-
32, which encompasses several putative nuclear localization signals,
had a critical function in its nuclear import (data not shown).
These results suggested that D1R stimulation acted by reducing the
export of DARPP-32 out of the nucleus. We ruled out a general
inhibitory influence of D1R stimulation on CRM1-dependent nuc-
lear export, by showing that SKF81297 did not alter the localization
of another protein with an active NES20, namely Ca21/calmodulin-
dependent kinase-Ia (CaMKIa–GFP; Fig. 2d). Introduction of an
ectopic NES sequence derived from prohibitin21 (NESproh) at the
carboxy terminus of DARPP-32 (D32–NESproh–GFP) blocked the
nuclear accumulation induced by SKF81297 (Fig. 2d).
To determine how the D1R/cAMP pathway regulated DARPP-32
localization we mutated its major phosphorylation sites (Thr 34,
Thr 75, Ser 97 and Ser 130; Fig. 2b) to alanine. In striatal neurons
in culture, basal and D1R-induced localization of T34A-D32–GFP,
T75A-D32–GFP and S130A-D32–GFPmutants was similar to that of
wild-type protein (Supplementary Fig. 6a). In support of these obser-
vations, in knock-in mutant mice bearing an alanine point mutation
at Thr 34 or Thr 75, the basal localization of DARPP-32 and its
cocaine-induced nuclear accumulation was similar to that of the wild
type (Supplementary Fig. 6b, c). In contrast, when Ser 97, located
close to the NES of DARPP-32, was mutated to alanine, the protein
was nuclear in basal conditions and D1R stimulation did not alter
this distribution (S97A-D32–GFP; Fig. 3a). Mutation of Ser 97 to the
acidic residues glutamate (S97E) or aspartate (S97D), which mimics
phosphorylation, induced a preferential cytoplasmic localization,
which was not modified by SKF81297 (Fig. 3a and Supplementary
Fig. 7a).
Ser 97 (Ser 102 in rat) is highly phosphorylated in basal
conditions by casein kinase 2 (CK2)22. An inhibitor of CK2,
4,5,6,7-tetrabromobenzotriazole (TBB)23, markedly increased nuc-
lear D32–GFP and prevented the effects of treatment with D1R ago-
nist (Fig. 3b and Supplementary Fig. 7b). The effects of TBB resulted
from the prevention of Ser 97 phosphorylation, because they were
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Figure 1 | Drugs of abuse and food self-administration induce nuclear
accumulation of DARPP-32 in striatal neurons. a, DARPP-32 (green) and
phospho-Thr 34-DARPP-32 (red) immunofluorescence in dorsal striatum
ofmice injectedwith saline or D-amphetamine (10mg kg21 intraperitoneally
for 15min). b, Effects of D-amphetamine (amph.), cocaine (20mg kg21, time
course) and morphine (mor., 5mg kg21 subcutaneously). Sal, saline.
c, Effects of 1 h of reinforcement learning: mice in self-administration
chamber without food (NF), learning to nose-poke for food pellets (active;
A) or receiving pellets when the active animal nose-poked (yoked; Y). Error
bars represent s.e.m., n5 4–8, t-test (amphetamine, morphine) or one-way
analysis of variance (Supplementary Table 1) and Bonferroni test. Asterisk,
P, 0.05; two asterisks, P, 0.01; three asterisks, P, 0.001. Single confocal
sections. Scale bars, 10 mm.
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Figure 2 | DARPP-32 undergoes continuous cyto-nuclear shuttling.
a, Leptomycin B (LMB; 10 ngml21) induces nuclear accumulation of
DARPP-32 in striatal neurons in culture. b, Putative NES in DARPP-32 and
major phosphorylation sites. c, Mutagenesis of hydrophobic residues inNES
increases nuclear localization of D32–GFP in transfected neurons. Three
asterisks, P, 0.001 compared with wild type (WT). d, Stimulation of D1R
(10 mM SKF81297 for 15min) has no effect on the localization of an
unrelated protein with a NES (CaMKIa–GFP) or when DARPP-32 contains
an additional NES (D32–NESproh–GFP). Three asterisks, P, 0.001 for SKF
compared with vehicle; three daggers, P, 0.001 for mutant compared with
WT. Error bars represent s.e.m., n5 3–6, one-way analysis of variance
(Supplementary Table 1), Bonferroni test.
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not observed with S97E-D32–GFP (Fig. 3c and Supplementary Fig.
7c). These results support the hypothesis that DARPP-32 is mainly
nuclear when Ser 97 is dephosphorylated, whereas it is preferentially
cytoplasmic when phosphorylated by CK2.
Protein phosphatase-2A dephosphorylates Ser 97
Because our results predicted that dephosphorylation of Ser 97
would enhance nuclear DARPP-32, we tested the role of protein
phosphatase-2A (PP2A), which dephosphorylates Ser 97 in vitro22.
Pretreatment of striatal neurons with okadaic acid, a potent inhibitor
of PP2A, did not alter the basal cytoplasmic localization of D32–GFP,
whereas it blocked its D1R-induced nuclear translocation (Fig. 3d
and Supplementary Fig. 7d). We next examined the regulation of
Ser 97 phosphorylation in striatal slices24. SKF81297 induced a
marked increase in Thr 34 phosphorylation, as expected, and a
dephosphorylation of Ser 97 (Fig. 3e). The precise time course of
the two responses was different, with dephosphorylation of Ser 97
being slower and more persistent than Thr 34 phosphorylation.
Forskolin, a potent activator of adenylyl cyclase, induced a pro-
nounced and sustained increase in Thr 34 phosphorylation and a
slightly delayed, but persistent, decrease in Ser 97 phosphorylation
(Fig. 3f and Supplementary Fig. 8). Forskolin-stimulated dephos-
phorylation of Ser 97 was prevented by okadaic acid (Fig. 3g), at a
concentration that blocks PP2A activity fully, and PP1 activity only
partly, in striatal slices25.
PP2A activity is controlled by various regulatory subunits, among
which the B56d subunit is highly expressed in the striatum (Sup-
plementary Fig. 9a) and is activated by cAMP-dependent phosphor-
ylation26,27. When B56d was co-expressed with DARPP-32 in
HEK293 cells, it promoted dephosphorylation of Ser 97 in response
to forskolin (Fig. 3h and Supplementary Fig. 9b). In contrast, in cells
transfected with the vector alone or with another isoform of the B
subunit (Ba), forskolin slightly increased Ser 97 phosphorylation
(Fig. 3h and Supplementary Fig. 9b). Thus, D1R stimulation and
increased cAMP levels induce the dephosphorylation of Ser 97 selec-
tively through stimulation of PP2A containing the B56d subunit.
Altered behaviour in S97A-DARPP-32 mice
To examine the role of Ser 97 in vivo, we used a knock-in mouse line
bearing a point mutation of this residue to alanine (S97A). DARPP-
32 was nuclear in about half of medium-size spiny neurons in the
various striatal regions of the mutant mice (Fig. 4a). Cocaine
injection did not alter the nuclear localization of S97A-DARPP-32
(Fig. 4a). The spontaneous activity, habituation and acute locomotor
response to cocaine were similar in S97A-DARPP-32 mice and wild-
type mice (Supplementary Fig. 10a–c), whereas the acute locomotor
response to morphine (5mg kg21) was decreased in the mutant
(Supplementary Fig. 10d). In wild-type mice a second injection of
cocaine or morphine, seven days after the first injection, had a much
stronger effect on locomotion than the first, showing a robust
sensitization (Supplementary Fig. 10e, f) as reported previously13.
In S97A-DARPP-32 mice, locomotor sensitization to cocaine and
morphine, although still present, was less pronounced than in
wild-type mice (Fig. 4b and Supplementary Fig. 10e, f). Moreover,
the rewarding effects of cocaine, evaluated by conditioned place
preference, were not observed in S97A-DARPP-32 mice (Fig. 4c).
We next examined whether mutation of Ser 97 interfered with
responses to physiological rewarding stimuli by using a model in
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Figure 3 | Phosphorylation at Ser 97 controls intracellular localization of
DARPP-32. a, Striatal neurons transfected with D1R and wild-type (WT),
S97A-D32–GFP, S97D-D32–GFP or S97E-D32–GFP, treated with vehicle
(Veh.,2) or 10 mM SKF81297 (SKF,1, 15min). Three asterisks, P, 0.001
for SKF compared with vehicle; two daggers, P, 0.01; three daggers,
P, 0.001 for mutant compared with WT. b, CK2 inhibition (TBB, 50 mM,
45min before SKF) increases nuclear DARPP-32. Three asterisks, P, 0.001
for SKF compared with vehicle; three daggers, P, 0.001 for TBB compared
with vehicle. c, S97E mutation prevents TBB effects. Three asterisks,
P, 0.001 for TBB compared with vehicle. d, Okadaic acid (OA; 500 nM,
45min before SKF) prevents D1R-induced DARPP-32 nuclear
accumulation. Three asterisks, P, 0.001 for SKF compared with vehicle;
three daggers, P, 0.001 for OA compared with vehicle. e, SKF81297
(10 mM) induces Thr 34 phosphorylation (blue) and Ser 97
dephosphorylation (red) in mouse striatal slices (immunoblotting;
n5 5–7). Two asterisks, P, 0.01; three asterisks, P, 0.001. f, Forskolin
(10 mM) also induces Thr 34 phosphorylation (blue) and Ser 97
dephosphorylation (red) (n5 5–7). Two asterisks, P, 0.01; three asterisks,
P, 0.001. g, Okadaic acid (1mM) prevents this forskolin-induced Ser 97
dephosphorylation. Three asterisks, P, 0.001 compared with control; two
double daggers, P, 0.01 compared with OA. h, B56d allows Ser 97
dephosphorylation by forskolin (Forsk., 10 mM, 10min): HEK293 cells
transfected with DARPP-32 and vector, B56d-PP2A or Ba-PP2A subunit
(immunoblotting, n5 3, t-test). Error bars represent s.e.m., one-way
ANOVA (Supplementary Table 1) and Bonferroni test (unless otherwise
indicated). Asterisk, P, 0.05.
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which mildly food-deprived mice learned to obtain food pellets by
nose-poking. Wild-type and mutant mice learned equally well, even
when the number of nose-pokes necessary to obtain a pellet was
increased to a fixed ratio of five or when the rewarded hole was
reversed (Supplementary Fig. 10g). However, when the required
number of nose-pokes was progressively increased until the mice
interrupted their behaviour, the breaking point was lower in S97A
mutant mice than in wild-type mice (Fig. 4d). Taken together, these
results show that mutation of Ser 97 alters long-lasting responses to
drugs of abuse, and decreases motivation for food reward.
In S97A-DARPP-32 mice we found a decreased phosphorylation
of DARPP-32 on Thr 34 and of several proteins regulated through
DARPP-32 (data not shown). We previously observed, with purified
bovine DARPP-32, that phosphorylation by CK2 facilitated the
phosphorylation of Thr 34 by PKA22. However, there was no deficit
in cAMP-induced Thr 34 phosphorylation of S97Amutant protein in
transfected COS7 cells in which overexpressed DARPP-32 was cyto-
plasmic (Supplementary Fig. 11). We therefore conclude that the
observed alterations in S97A mice probably resulted from the block-
ade of cyto-nuclear shuttling of DARPP-32, rather than from an
intrinsic effect of Ser 97 phosphorylation on Thr 34 phosphorylation.
Nuclear DARPP-32 regulates histone H3 phosphorylation
Because D1R stimulation induces the accumulation of Thr 34-
phospho-DARPP-32 (Fig. 1a), a potent inhibitor of PP1, we
proposed that DARPP-32 translocation might regulate the phos-
phorylation of nuclear proteins. We therefore investigated the
phosphorylation of histone H3 on Ser 10, a substrate for several
kinases28,29, which is known to be regulated by PP1 (refs 30, 31).
The phosphorylation of H3 on Ser 10 is a key step in nucleosomal
response28,32 and is crucial for memory formation33. It is increased in
the striatum after cocaine administration in vivo, and this response is
functionally important14,34. Cocaine induced an intense phospho-
Ser 10-H3 signal in the nuclei of several striatal neurons in wild-type
mice, whereas this effect was absent in both T34A-DARPP-32 and
S97A-DARPP-32 mice (Fig. 5a). Similar results were observed with
an antibody that detected phospho-acetyl-H3 (phospho-Ser 10-
acetyl-Lys 14-H3; data not shown).
In striatal neurons transfected with D1R and D32–GFP, the D1R
agonist SKF81297 markedly increased the phosphorylation of H3 on
Ser 10 (Fig. 5b, c, and Supplementary Fig. 12). SKF81297 did not alter
the acetylation of H3 on Lys 14, but increased the immunoreactivity
of phospho-Ser 10, acetyl-Lys 14 H3 (Fig. 5b and Supplementary
Fig. 12). D1R-induced phosphorylation of histone H3 was lost when
neurons were transfected with T34A-D32–GFP instead of the wild
type (Fig. 5c), confirming that the ability of DARPP-32 to inhibit PP1
was essential for H3 phosphorylation. We then directly evaluated the
role of DARPP-32 translocation to the nucleus by using mutant
forms of D32–GFP that are constitutively excluded from the nucleus:
S97E-D32–GFP (see Fig. 3a) and DARPP-32-NESproh–GFP (see
Fig. 2d). In neurons transfected with these ‘cytoplasmic’ variants of
D32–GFP, the D1R agonist SKF81297 did not induce H3 phosphor-
ylation (S97E and NESproh; Fig. 5c). These results showed that
DARPP-32 phosphorylation on Thr 34, and thus PP1 inhibition,
was essential for D1R-induced phosphorylation of Ser 10-H3 and
that this effect required the ability of DARPP-32 to accumulate in
the nucleus in response to stimulation of D1R.
Discussion
Our study identifies nuclear DARPP-32 as a key factor in the phos-
phorylation of histoneH3, a component of the nucleosomal response
that is essential for gene expression28,32,33. Psychostimulant drugs (D-
amphetamine and cocaine) and morphine, which act by completely
differentmechanisms, share the ability to increase extracellular dopa-
mine in the NAc and to trigger the nuclear accumulation of DARPP-
32. A natural stimulus such as a simple food-reinforced learning
model caused a similar effect. DARPP-32 undergoes a very active,
continuous cyto-nuclear shuttling regulated by the phosphorylation
of Ser 97, which is in the vicinity of its NES (summarized in Fig. 5d).
Phosphorylation of Ser 97 by CK2 seems to be crucial for the nuclear
export of DARPP-32. CK2 is present in nuclei of striatal neurons
(Supplementary Fig. 13) and can phosphorylate nuclear DARPP-32
and promote its export. Stimulation of D1R triggers the rapid
phosphorylation of Thr 34 responsible for cytoplasmic effects of
DARPP-32, and the slower dephosphorylation of Ser 97, by acti-
vating PP2A through cAMP/PKA-mediated phosphorylation of its
B56d subunit26,27, thus decreasing the nuclear export of DARPP-32.
Although phosphorylation has been reported to regulate the cyto-
nuclear shuttling of several proteins35, this is a rare example of
facilitation of CRM1-mediated nuclear export by phosphor-
ylation36,37. cAMP-independent mechanisms also couple dopamine
D2 receptor (D2R) to a delayed activation of PP2A (ref. 38). D2R
does not seem to be important in the early nuclear accumulation of
DARPP-32, but it could have a regulatory role on Ser 97 phosphor-
ylation and DARPP-32 localization in other circumstances.
A large body of evidence demonstrates that long-term synaptic
plasticity requires the control of gene expression in the striatum as
in other brain regions39. We have identified a previously unrecog-
nized mechanism by which dopamine controls chromatin through
the regulated translocation of a PP1 inhibitor to the nucleus, which
promotes histone H3 phosphorylation. Dopamine-controlled
inhibition of nuclear PP1, a wide-spectrum protein phosphatase, is
likely to have other targets, making it a general means for the control
of nuclear function. This mechanism is undoubtedly important in
the long-term effects of drugs of abuse, which activate gene transcrip-
tion through the stimulation of D1R, and in physiological reward-
controlled learning. Regulation of the nuclear accumulation of
dcb
Core Shell
AccumbensDorsal
striatum
75
3
400
1,500
1,000
500
0
300
200
100
0
–100
2
1
0
P
er
ce
nt
ag
e 
of
 n
eu
ro
ns
w
ith
 n
uc
le
ar
 D
A
R
P
P
-3
2
S
en
si
tiz
at
io
n 
ra
tio
,
in
je
ct
io
n 
2/
in
je
ct
io
n 
1
S
co
re
s 
(s
)
B
re
ak
in
g 
p
oi
nt
,
no
. o
f p
ok
es
50
25
0
75
S C S C
WT S97A
WT S97A WT
WT
S97A S C
S97A
WT S97AS C
Cocaine Morphine
S C S C
WT S97A
S C S C
WT S97A
50
25
0
75
50
25
0
S97A
WT
DARPP-32
CocaineSalinea
††
††
†
Figure 4 | Mutation of Ser 97 alters localization of DARPP-32, behavioural
responses to drugs of abuse and motivation for food reward. a, DARPP-32
immunoreactivity (dorsal striatum) in wild-type (WT) or S97A-DARPP-32
mice injected with saline (S) or cocaine (C, 20mg kg21, for 10min). Single
confocal sections. Scale bar, 10mm; n5 3–8. Asterisk, P, 0.05; two
asterisks, P, 0.01 for saline compared with cocaine; dagger, P, 0.05; two
daggers, P, 0.01 for S97A compared with WT. b, Decreased locomotor
sensitization to a second injection (day 7) of cocaine (20mg kg21, for 1 h;
n5 16) or morphine (5mg kg21, for 3 h; n5 8) in S97A mice (t-test).
Asterisk, P, 0.05. c, Conditioned place preference to cocaine was prevented
in S97A mice (scores are calculated as time in cocaine-paired compartment
after conditioning minus that before conditioning; n5 7–8). Two asterisks,
P, 0.01. d, Decreased breaking point for food reward under progressive
ratio schedule in S97A mice (t-test, n5 7–8). Error bars represent s.e.m.,
two-way analysis of variance (Supplementary Table 1) and Bonferroni test
(unless otherwise indicated). Asterisk, P, 0.05.
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DARPP-32may also be important to the functions or dysfunctions of
dopamine that involve transcription-dependent long-term plasticity,
including neuroleptic- and L-DOPA-induced dyskinesia, and other
diseases of the basal ganglia.
METHODS SUMMARY
Knock-in T34A-DARPP-32, T75A-DARPP-32 and S97A-DARPP-32 (refs 40,
41), D1R-deficient42, drd1a-EGFP17 and matched wild-type control mice were
habituated to saline injections for three days before experiments. Drug-treated
mice were anaesthetized with pentobarbital and received an intracardiac per-
fusion of 4% paraformaldehyde. Vibratome-cut brain sections were processed
for immunofluorescence13. Primary striatal neurons, from 14-day embryonic
Swiss mice, were grown in supplemented Neurobasal medium and transfected
aweek later with plasmids expressingD1R andDARPP-32 fusedwithC-terminal
EGFP (D32–GFP). HEK293, CHO-K1 or COS-7 cells were transfected with
DARPP-32 constructs associated or not with PP2A subunits, and studied 24–
48 h later. On the basis of confocal single sections, the subcellular localization of
DARPP-32 or GFP was classified into three categories: nuclear staining stronger
than, equal to or weaker than cytoplasmic. For cells in culture, the first two
categories were pooled and considered as cells with nuclear staining.
Phosphorylated and/or acetylated H3 immunofluorescence was quantified with
Image-J-1.34s (National Institutes of Health). Striatal coronal slices (350 mm)
were incubated in oxygenated artificial cerebrospinal fluid25, and phospho-
DARPP-32 was analysed in slices or transfected cells by western blotting25.
Locomotor activity, sensitization produced by a single injection of drug, and
conditioned place preference were measured as described13,14,43. In the operant
model for food self-administration (incentive learning), mildly food-deprived
mice were placed in an operant chamber with two nose-poke holes. One or five
nose-pokes (fixed ratios 1 and 5) in the rewarded hole, indicated by a cue light,
triggered the release of a food pellet. Controls were ‘no food’ mice (mice in the
same chamber but with no pellet delivered) and ‘yoked’ mice (paired to active
mice, in exactly the same conditions, but rewarded when the active mouse nose-
poked). For the reversal test, the previously inactive hole became active and vice
versa. For analysis of the progressive ratio, the number of successive pokes
required for pellet release was progressively increased until the mouse stopped
poking (breaking point).
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Animals. Male eight-week-old C57BL/6J mice from Elevage Janvier or Japan-
SLC were used for in vivo and slice experiments, respectively. Production of
knock-inT34A-DARPP-32, T75A-DARPP-32 and S97A-DARPP-32mutant40,41,
D1R-deficient42 and drd1a-EGFP17 mice were described previously. Mutant and
wild-typemice used in experiments, or their parents, were littermates.Mice were
kept for at least one week in a local animal house in stable conditions (22 uC,
12 h/12 h light/dark cycle, free access to food and water). During the three days
preceding the experiments, mice were habituated to behavioural apparatus,
when applicable, and to injections by daily intraperitoneal saline administration.
Animal care was in accordance with ethical guidelines (Declaration of Helsinki
and NIH, publication no. 85-23, revised 1985, European Community
Guidelines, and French Agriculture and Forestry Ministry guidelines for hand-
ling animals, decree 87849, license A 75-05-22) and approved by the local ethical
committees.
Drugs. (1)-D-Methylphenethylamine (D-amphetamine) sulphate salt, cocaine-
HCl, SKF81297, SCH23390 (both in 0.1% v/v dimethylsulphoxide) and okadaic
acid potassium salt were from Sigma-Aldrich or Tocris; morphine sulphate
salt was from Francopia; 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole-39,59-
cyclic-monophosphoro-thioate, Sp-isomer (Sp-5,6-DCl-cBIMPS) andadenosine-
39,59-cyclic-mono-phosphorothioate, Rp-isomer (Rp-cAMPS) were from Biolog;
leptomycin-B was from Amersham; 4,5,6,7-tetrabromobenzotriazole (50mM in
0.1% dimethylsulphoxide) was from Calbiochem. For in vivo experiments, drugs
were dissolved in 0.9%NaCl and injected intraperitoneally (i.p.) exceptmorphine,
which was injected subcutaneously (s.c.).
Plasmid constructs and DARPP-32 mutants. Rattus norvegicus DARPP-32
cDNA (mouse residue numbering is used throughout) was amplified by PCR
with Pfu (Stratagene) and cloned in the XhoI/EcoRI sites of EGFP-N2
(Clontech), and subjected to site-directed mutagenesis (Quick-Change;
Stratagene). DARPP-32-NESproh was constructed by EcoRI/SalI digestion and
ligation of a sequence encoding AAEDIAYQLSRSRNITYLPAGQSVLLQLPQ
(NES of prohibitin; ref. 21) to the C terminus of DARPP-32. Constructs were
verified by DNA sequencing. CaMKIa–GFP and pRK5-D1R were gifts.
Cell culture and transfection. Striatal neurons (180,000 per well) from 14-day
embryonic Swiss mice (Janvier) were transfected after seven days in culture14
with D32–GFP (1mg) and pRK5-D1R (1mg) DNA, using Lipofectamine 2000 in
OptiMEM serum-free medium. Treatments were done 24 h later, in fresh
Neurobasal medium. CHO-K1 cells (American Type Culture Collection)
(25,000 cells per 14-mm diameter coverslip) were cultured in Ham’s F-12
medium with 10% foetal bovine serum (FBS). COS-7 and HEK293 cells were
cultured in six-well plates (106 per well) in DMEM medium with 10% FBS.
Culture media were from Invitrogen. CHO-K1 and COS-7 cells were transfected
as neurons with D32–GFP DNA (1mg). HEK293 cells were co-transfected with
Myc-tagged DARPP-32 (0.5mg) and Flag-tagged B-subunits of PP2A vector, Ba
or B56d (0.5mg) DNA, using Fugene-6 (Roche). After 48 h, cells were treated
with forskolin and lysed in 150ml of 50mMTris-HCl pH7.4, 150mMNaCl, 1%
Triton X-100, 0.1% SDS, protease inhibitor cocktail (Roche) and phosphatase
inhibitor cocktail I and II (Calbiochem), sonicated for 5 s, and centrifuged for
10min at 16,000g.
Immunostaining of striatal neurons in culture. Cells were fixed with PBS
containing 2% paraformaldehyde (40min, 20–23 uC) and incubated with
methanol/acetone (1:1, 10min, 4 uC). After three rinses in PBS, cells were treated
with blocking buffer (3% BSA in PBS except for H3 immunofluorescence: 1%
BSA and 1% FBS) for 45min (2 h for P-Ser 10-H3) at room temperature.
Coverslips were incubated overnight at 4 uC in PBS with 1% BSA and
DARPP-32 (1:4,000 dilution) and D1R (1:500 dilution) monoclonal antibodies.
P-Ser 10-H3, acetyl-Lys 14-H3 and P-Ser 10-acetyl-Lys 14-H3 antibodies
(1:1,000 dilution; Upstate) were added overnight at 4 uC in PBS containing
1% BSA and 0.05% Tween 20. Anti-mouse Alexa488-conjugated antibody or
anti-mouse Cy3-conjugated antibody (1:400 dilution; Molecular Probes) were
added for 1 h at room temperature. Nuclei were counterstained with SYTOX
(1:2,000 dilution; Molecular Probes). Cells rinsed three times were mounted
under coverslips with Vectashield (Vector Laboratories).
Immunohistofluorescence of brain sections and subcellular distribution
of DARPP-32. Brains from paraformaldehyde-perfused mice were postfixed
and 30-mm sections were cut with a vibratome (Leica)13,44. Free-floating sections
were incubated overnight with antibodies at 4 uC, and after rinses in TBS, for 2 h
at room temperature with secondary antibody (1:400 dilution; Cy3-coupled
anti-rabbit IgG or Alexa488-conjugated anti-mouse antibodies; Molecular
Probes). Nuclei were counterstained with 1 mM TO-PRO-3 iodide (Molecular
Probes). Sections were rinsed three times in TBS and mounted in Vectashield.
Image acquisition and statistical analysis. Image acquisition with sequential
laser scanning confocalmicroscopy (SP2; Leica) was performed at the Institut du
Fer a`Moulin Imaging Facility. For brain immunofluorescence, two sectionswere
analysed bilaterally and cells were counted in one field for dorsal striatum, NAc
shell and core (data points for an animal correspond to four acquisitions per
structure). For cultures, data points correspond to a minimum of 15 transfected
cells (minimum of two different experiments with three independent transfec-
tions). Data were analysed with Prism (GraphPad) software, using parametric or
non-parametric statistics as indicated, depending on the normality of the dis-
tribution of variables.
Behavioural analysis. Locomotor activity was measured in a circular corridor
(Imetronic)13. Mice were placed in the corridor 30min before injection for the
acute experiments. Locomotor sensitization was induced by a single injection of
cocaine or morphine13,43. Food self-administration experiments were conducted
in operant chambers (Imetronic) with two holes, one being the active hole,
indicated by a cue light. Nose-poking in the active hole resulted in delivery of
a food pellet (Phymep). The light was switched off for 10 s after the consumption
of the food pellet, during which no reward was provided. Mice were food-
deprived (3.5 g/d, water ad libitum) starting five days before the experiment,
to reach 85% of initial weight. Self-administration sessions (1 h per day) were
conducted five days per week. Mice were trained under a fixed ratio 1 (FR1, 1
pellet per nose poke) schedule. The session was terminated after 100 pellets or
1 h. Acquisition criteria were: stable response with less than 20% deviation from
the mean of the total number of reinforcers earned in three consecutive sessions
(80% stability). Criteria were then changed to a fixed ratio 5 (FR5, 1 pellet per 5
nose pokes) schedule. When the 80% stability criterion had been reached, a
reversal procedure was started (rFR5). During reversal the previously active hole
became inactive, and vice versa. When the same criteria as above had been met,
mice were subjected to a single 2-h progressive ratio (PR) session in which the
requirement to earn a pellet escalated according to the following series: 1, 2, 3, 5,
12, 18, 27, 40, 60, 90, 135, 200, 300, 450, 675, 1,000, 1,500.
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